Results 121 to 130 of about 3,002 (191)

Updated Viloxazine Pharmacology: Experiments Establish Norepinephrine Transporter Occupancy and Serotonin 5-HT_2C, 5-HT_2B, and 5-HT₇ Receptor Binding at Therapeutically Relevant Concentrations. [PDF]

Drugs R D
Garcia-Olivares J, Yegla B, Koch J, Yu C, Rubin J.   +4 more
europepmc   +1 more source

Comparison of the function of two novel human dopamine D2 receptor variants identifies a likely mechanism for their pathogenicity. [PDF]

Biochem Pharmacol
Rodriguez-Contreras D, García-Nafría J, Chan AE, Shinde U, Neve KA.   +4 more
europepmc   +1 more source

Is It Scientifically Possible To 'Cure" Reward Deficiency Syndrome (RDS) Via Transplice Molecular Genetic Technology? [PDF]

Acta Sci Neurol
Blum K, Sharafshah A, -Uwe-Lewandowski K, Pinhasov A, Elman I, Thanos PK, Baron D, Dennen CA, Bowirrat A, Modestino EJ, Gold MS, Lewandowski AP, Fliegelman C, Badgaiyan RD.   +13 more
europepmc   +1 more source

Opioid/Dopamine Receptor Binding Studies, NMR and Molecular Dynamics Simulation of LENART01 Chimera, an Opioid-Bombesin-like Peptide. [PDF]

Molecules
Serafin P, Szeleszczuk Ł, Zhukov I, Szűcs E, Gombos D, Stefanucci A, Mollica A, Pisklak DM, Kleczkowska P.   +8 more
europepmc   +1 more source

Design, synthesis, drug-likeness, and molecular dynamics evaluations of monobrominated amathamide G analogs as potential ligands for D2-like dopamine receptors. [PDF]

In Silico Pharmacol
Navarrete-Gutiérrez A, Frías-Aviña O, Montes-Ávila J, Argüello-García R, Pech-Santiago EO, Aguirre-Hernández G.   +5 more
europepmc   +1 more source

Experimental and machine learning-based exploration of repurposed drugs reveals chemical features underlying phospholipidosis. [PDF]

Patterns (N Y)
Kuzikov M, Kalman A, Karki R, Reinshagen J, Huchting J, Qian K, Axelsson H, Tampere M, Östling P, Seashore-Ludlow B, Gadiya Y, Gribbon P, Zaliani A.   +12 more
europepmc   +1 more source

A comprehensive analysis of propofol abuse, addiction and neuropharmacological aspects: an updated review. [PDF]

Korean J Anesthesiol
Uzbay T, Shahzadi A.
europepmc   +1 more source

An Open-Label Study Investigating the 5-HT_2A Receptor Occupancy of Remlifanserin (ACP-204) With the PET Radioligand [¹⁸F]Altanserin in Healthy Male Participants. [PDF]

Clin Pharmacol Drug Dev
Burstein ES, Sandiego C, Raether B, Feng X, Dirks B, Darwish M, Zhang P, Russell DS, Rabiner EA, Pathak S.   +9 more
europepmc   +1 more source

A Pharmacovigilance Study on Psychotropic Agent-Induced Urinary Retention Using the Japanese Adverse Drug Event Report Database. [PDF]

Drugs Real World Outcomes
Uekusa S, Mogi K, Ota Y, Hanai Y, Kitagawa K, Yoshio T, Matsuo K.   +6 more
europepmc   +1 more source

Gepirone for Major Depressive Disorder: From Pharmacokinetics to Clinical Evidence: A Narrative Review. [PDF]

Int J Mol Sci
Gałka N, Tomaka E, Tomaszewska J, Pańczyszyn-Trzewik P, Sowa-Kućma M.   +4 more
europepmc   +1 more source